Literature DB >> 29787238

Antifibrotic Effect of Ketoprofen-Grafted Alginate Microcapsules in the Transplantation of Insulin Producing Cells.

François Noverraz1, Elisa Montanari2, Joël Pimenta2, Luca Szabó1, Daniel Ortiz3, Carmen Gonelle-Gispert2, Léo H Bühler2, Sandrine Gerber-Lemaire1.   

Abstract

The controlled release of small molecular modulators of the immune response from hydrogel microspheres (MS) used for cell immobilization is an attractive approach to reduce pericapsular fibrotic overgrowth (PFO) after transplantation. Ketoprofen is a well-known nonsteroidal anti-inflammatory drug involved in the early stage inflammation cascade. PEGylated derivatives of ketoprofen, presenting either ester or amide linkage to the drug, were synthesized and conjugated to the hydroxyl groups of sodium alginate (Na-alg). Functionalized cell-free and MIN6 cells containing MS were produced from the resulting modified alginates. In vitro quantification of ketoprofen release indicated regular and sustained drug delivery over 14 days, resulting from the hydrolytic cleavage of the ester bond. The release kinetics was enhanced over the initial 7 days by the presence of MIN6 cells, probably as a result of cell esterase activity. In the presence of amide bond, traces of ketoprofen were released over 14 days due to a much slower hydrolysis kinetics. Cell-free and MIN6 cells containing MS were transplanted in immune-competent mice, either in the peritoneal cavity or under the kidney capsule, with a follow-up period of 30 days. Comparison with nonmodified Ca-alg MS transplanted in the same conditions demonstrated a clear reduction in the severity of PFO for MS functionalized with ketoprofen. Quantification of collagen deposition on MIN6 cells containing MS transplanted under the kidney capsule revealed the significant effect of ketoprofen release to decrease fibrotic tissue formation. The impact was more pronounced when the drug was covalently conjugated by an ester linkage, allowing higher concentration of the anti-inflammatory compound to be delivered at the transplantation site. The functionality of microencapsulated MIN6 cells 30 days after transplantation was confirmed by detection of insulin positive cell content.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29787238     DOI: 10.1021/acs.bioconjchem.8b00190

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  4 in total

1.  Systemic Immunotherapy with Micellar Resiquimod-Polymer Conjugates Triggers a Robust Antitumor Response in a Breast Cancer Model.

Authors:  Hamilton Kakwere; Hua Zhang; Elizabeth S Ingham; Marina Nura-Raie; Spencer K Tumbale; Riley Allen; Sarah M Tam; Bo Wu; Cheng Liu; Azadeh Kheirolomoom; Brett Z Fite; Asaf Ilovitsh; Jamal S Lewis; Katherine W Ferrara
Journal:  Adv Healthc Mater       Date:  2021-03-01       Impact factor: 9.933

Review 2.  Drug delivery carriers with therapeutic functions.

Authors:  Shuting S Cai; Tianyu Li; Tolulope Akinade; Yuefei Zhu; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2021-07-21       Impact factor: 17.873

Review 3.  Strategies to Functionalize the Anionic Biopolymer Na-Alginate without Restricting Its Polyelectrolyte Properties.

Authors:  Luca Szabó; Sandrine Gerber-Lemaire; Christine Wandrey
Journal:  Polymers (Basel)       Date:  2020-04-15       Impact factor: 4.329

Review 4.  The emerging field of pancreatic tissue engineering: A systematic review and evidence map of scaffold materials and scaffolding techniques for insulin-secreting cells.

Authors:  Gabriel Alexander Salg; Nathalia A Giese; Miriam Schenk; Felix J Hüttner; Klaus Felix; Pascal Probst; Markus K Diener; Thilo Hackert; Hannes Götz Kenngott
Journal:  J Tissue Eng       Date:  2019-10-30       Impact factor: 7.813

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.